Westpac Banking Corp lowered its position in Cigna Corp (NYSE:CI) by 63.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 39,835 shares of the health services provider’s stock after selling 69,402 shares during the quarter. Westpac Banking Corp’s holdings in Cigna were worth $6,276,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently added to or reduced their stakes in the company. Geode Capital Management LLC lifted its holdings in shares of Cigna by 61.3% during the 4th quarter. Geode Capital Management LLC now owns 4,939,173 shares of the health services provider’s stock worth $936,405,000 after acquiring an additional 1,876,556 shares during the period. Sumitomo Life Insurance Co. lifted its holdings in shares of Cigna by 124.3% during the 1st quarter. Sumitomo Life Insurance Co. now owns 8,424 shares of the health services provider’s stock worth $1,355,000 after acquiring an additional 4,669 shares during the period. Carroll Financial Associates Inc. lifted its holdings in shares of Cigna by 10.8% during the 1st quarter. Carroll Financial Associates Inc. now owns 844 shares of the health services provider’s stock worth $135,000 after acquiring an additional 82 shares during the period. Wedbush Securities Inc. lifted its holdings in shares of Cigna by 5.2% during the 1st quarter. Wedbush Securities Inc. now owns 5,373 shares of the health services provider’s stock worth $864,000 after acquiring an additional 267 shares during the period. Finally, IFM Investors Pty Ltd lifted its holdings in shares of Cigna by 14.5% during the 1st quarter. IFM Investors Pty Ltd now owns 25,099 shares of the health services provider’s stock worth $4,036,000 after acquiring an additional 3,173 shares during the period. 87.92% of the stock is owned by institutional investors.

Shares of Cigna stock traded up $2.81 during mid-day trading on Friday, reaching $162.51. 31,402 shares of the stock were exchanged, compared to its average volume of 1,813,190. The company has a market cap of $63.99 billion, a price-to-earnings ratio of 11.40, a price-to-earnings-growth ratio of 0.87 and a beta of 0.70. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.84. The firm has a 50-day simple moving average of $167.64 and a 200 day simple moving average of $165.91. Cigna Corp has a fifty-two week low of $141.95 and a fifty-two week high of $226.60.

Cigna (NYSE:CI) last posted its quarterly earnings data on Thursday, August 1st. The health services provider reported $4.30 earnings per share for the quarter, beating the consensus estimate of $3.74 by $0.56. The firm had revenue of $34.38 billion during the quarter, compared to analysts’ expectations of $33.27 billion. Cigna had a net margin of 3.60% and a return on equity of 13.24%. The company’s quarterly revenue was up 198.9% compared to the same quarter last year. During the same quarter last year, the company posted $3.89 EPS. On average, research analysts predict that Cigna Corp will post 16.59 EPS for the current fiscal year.

CI has been the subject of a number of analyst reports. Zacks Investment Research downgraded shares of Cigna from a “buy” rating to a “hold” rating and set a $164.00 price objective for the company. in a report on Tuesday, June 11th. Morgan Stanley dropped their target price on shares of Cigna from $241.00 to $207.00 and set an “overweight” rating for the company in a research report on Friday, July 12th. Raymond James increased their target price on shares of Cigna from $185.00 to $190.00 and gave the stock an “outperform” rating in a research report on Friday, August 2nd. UBS Group started coverage on shares of Cigna in a research report on Tuesday, April 23rd. They set a “buy” rating and a $185.00 target price for the company. Finally, ValuEngine cut shares of Cigna from a “hold” rating to a “sell” rating in a research report on Tuesday, July 23rd. One research analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $214.55.

Cigna Company Profile

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Recommended Story: Ex-Dividend

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.